CorMedix Inc. (CRMD) Stock Ticker
CRMD right now
Market factors today
Unlock the full CRMD picture
About CorMedix Inc.
CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.
CRMD stock facts
| Ticker symbol | CRMD |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $615.8M |
| CEO | Joseph Todisco |
| Employees | 191 |
| Headquarters | Parsippany, NJ, US |
| IPO date | 2010-05-13 |
| Website | www.cormedix.com |
What you can see for CRMD on Tickr
Live CRMD price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the CRMD report.
Rankings
FAQ
What is the ticker symbol for CorMedix Inc.?
The ticker symbol for CorMedix Inc. is CRMD, listed on the NASDAQ Global Market.
What is CRMD?
CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert…